Moderna stock more than doubles after melanoma vaccine trial shows "landmark moment"

Source CBS Local
Original Load Date Aug. 19, 2026, 11 a.m.
Last Updated Aug. 19, 2026, 11 a.m.
Original URL https://www.cbsnews.com/chicago/news/moderna-stock-melanoma-cancer-vaccine/

Article Preview

Drugmaker Moderna's stock more than doubled on Wednesday morning after the company announced a successful experimental mRNA vaccine to treat [ melanoma ][2] , the deadly skin cancer from which more than [ 8,500 people ][3] in the U.S. are expected to die this year. Moderna and Merck, its drug devel...